2024-01-012024-12-312024-12-31false08357958Medishout Ltd2025-07-1561900falseiso4217:GBPxbrli:pure083579582023-12-31083579582024-12-31083579582024-01-012024-12-31083579582022-09-30083579582023-12-31083579582022-10-012023-12-3108357958bus:SmallEntities2024-01-012024-12-3108357958bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3108357958bus:FullAccounts2024-01-012024-12-3108357958bus:PrivateLimitedCompanyLtd2024-01-012024-12-3108357958core:WithinOneYear2024-12-3108357958core:AfterOneYear2024-12-3108357958core:WithinOneYear2023-12-3108357958core:AfterOneYear2023-12-3108357958core:ShareCapital2024-12-3108357958core:SharePremium2024-12-3108357958core:RevaluationReserve2024-12-3108357958core:OtherReservesSubtotal2024-12-3108357958core:RetainedEarningsAccumulatedLosses2024-12-3108357958core:ShareCapital2023-12-3108357958core:SharePremium2023-12-3108357958core:RevaluationReserve2023-12-3108357958core:OtherReservesSubtotal2023-12-3108357958core:RetainedEarningsAccumulatedLosses2023-12-3108357958core:LandBuildings2024-12-3108357958core:PlantMachinery2024-12-3108357958core:Vehicles2024-12-3108357958core:FurnitureFittings2024-12-3108357958core:OfficeEquipment2024-12-3108357958core:NetGoodwill2024-12-3108357958core:IntangibleAssetsOtherThanGoodwill2024-12-3108357958core:ListedExchangeTraded2024-12-3108357958core:UnlistedNon-exchangeTraded2024-12-3108357958core:LandBuildings2023-12-3108357958core:PlantMachinery2023-12-3108357958core:Vehicles2023-12-3108357958core:FurnitureFittings2023-12-3108357958core:OfficeEquipment2023-12-3108357958core:NetGoodwill2023-12-3108357958core:IntangibleAssetsOtherThanGoodwill2023-12-3108357958core:ListedExchangeTraded2023-12-3108357958core:UnlistedNon-exchangeTraded2023-12-3108357958core:LandBuildings2024-01-012024-12-3108357958core:PlantMachinery2024-01-012024-12-3108357958core:Vehicles2024-01-012024-12-3108357958core:FurnitureFittings2024-01-012024-12-3108357958core:OfficeEquipment2024-01-012024-12-3108357958core:NetGoodwill2024-01-012024-12-3108357958core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3108357958core:ListedExchangeTraded2024-01-012024-12-3108357958core:UnlistedNon-exchangeTraded2024-01-012024-12-3108357958core:MoreThanFiveYears2024-01-012024-12-3108357958core:Non-currentFinancialInstruments2024-12-3108357958core:Non-currentFinancialInstruments2023-12-3108357958dpl:CostSales2024-01-012024-12-3108357958dpl:DistributionCosts2024-01-012024-12-3108357958core:LandBuildings2024-01-012024-12-3108357958core:PlantMachinery2024-01-012024-12-3108357958core:Vehicles2024-01-012024-12-3108357958core:FurnitureFittings2024-01-012024-12-3108357958core:OfficeEquipment2024-01-012024-12-3108357958dpl:AdministrativeExpenses2024-01-012024-12-3108357958core:NetGoodwill2024-01-012024-12-3108357958core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3108357958dpl:GroupUndertakings2024-01-012024-12-3108357958dpl:ParticipatingInterests2024-01-012024-12-3108357958dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3108357958core:ListedExchangeTraded2024-01-012024-12-3108357958dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3108357958core:UnlistedNon-exchangeTraded2024-01-012024-12-3108357958dpl:CostSales2022-10-012023-12-3108357958dpl:DistributionCosts2022-10-012023-12-3108357958core:LandBuildings2022-10-012023-12-3108357958core:PlantMachinery2022-10-012023-12-3108357958core:Vehicles2022-10-012023-12-3108357958core:FurnitureFittings2022-10-012023-12-3108357958core:OfficeEquipment2022-10-012023-12-3108357958dpl:AdministrativeExpenses2022-10-012023-12-3108357958core:NetGoodwill2022-10-012023-12-3108357958core:IntangibleAssetsOtherThanGoodwill2022-10-012023-12-3108357958dpl:GroupUndertakings2022-10-012023-12-3108357958dpl:ParticipatingInterests2022-10-012023-12-3108357958dpl:GroupUndertakingscore:ListedExchangeTraded2022-10-012023-12-3108357958core:ListedExchangeTraded2022-10-012023-12-3108357958dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-10-012023-12-3108357958core:UnlistedNon-exchangeTraded2022-10-012023-12-3108357958core:NetGoodwill2024-12-3108357958core:IntangibleAssetsOtherThanGoodwill2024-12-3108357958core:LandBuildings2024-12-3108357958core:PlantMachinery2024-12-3108357958core:Vehicles2024-12-3108357958core:FurnitureFittings2024-12-3108357958core:OfficeEquipment2024-12-3108357958core:AfterOneYear2024-12-3108357958core:WithinOneYear2024-12-3108357958core:ListedExchangeTraded2024-12-3108357958core:UnlistedNon-exchangeTraded2024-12-3108357958core:ShareCapital2024-12-3108357958core:SharePremium2024-12-3108357958core:RevaluationReserve2024-12-3108357958core:OtherReservesSubtotal2024-12-3108357958core:RetainedEarningsAccumulatedLosses2024-12-3108357958core:NetGoodwill2023-12-3108357958core:IntangibleAssetsOtherThanGoodwill2023-12-3108357958core:LandBuildings2023-12-3108357958core:PlantMachinery2023-12-3108357958core:Vehicles2023-12-3108357958core:FurnitureFittings2023-12-3108357958core:OfficeEquipment2023-12-3108357958core:AfterOneYear2023-12-3108357958core:WithinOneYear2023-12-3108357958core:ListedExchangeTraded2023-12-3108357958core:UnlistedNon-exchangeTraded2023-12-3108357958core:ShareCapital2023-12-3108357958core:SharePremium2023-12-3108357958core:RevaluationReserve2023-12-3108357958core:OtherReservesSubtotal2023-12-3108357958core:RetainedEarningsAccumulatedLosses2023-12-3108357958core:NetGoodwill2022-09-3008357958core:IntangibleAssetsOtherThanGoodwill2022-09-3008357958core:LandBuildings2022-09-3008357958core:PlantMachinery2022-09-3008357958core:Vehicles2022-09-3008357958core:FurnitureFittings2022-09-3008357958core:OfficeEquipment2022-09-3008357958core:AfterOneYear2022-09-3008357958core:WithinOneYear2022-09-3008357958core:ListedExchangeTraded2022-09-3008357958core:UnlistedNon-exchangeTraded2022-09-3008357958core:ShareCapital2022-09-3008357958core:SharePremium2022-09-3008357958core:RevaluationReserve2022-09-3008357958core:OtherReservesSubtotal2022-09-3008357958core:RetainedEarningsAccumulatedLosses2022-09-3008357958core:AfterOneYear2024-01-012024-12-3108357958core:WithinOneYear2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3108357958core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3108357958core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3108357958core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3108357958core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3108357958core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3108357958core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3108357958core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3108357958core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3108357958core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3108357958bus:Director12024-01-012024-12-3108357958bus:Director22024-01-012024-12-3108357958bus:Director32024-01-012024-12-3108357958bus:Director42024-01-012024-12-3108357958bus:Director52024-01-012024-12-310835795812024-01-012024-12-31

Medishout Ltd

Registered Number
08357958
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

Medishout Ltd
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

BAHSOUN, Ali Nehme
GIBBS, Keith George
KALRAIYA, Ashish Jain, Dr
MURDOCH, Simon Thomas
SHAH, Saavan

Registered Address

2 Sherrock Gardens
Hendon
London
NW4 4JJ

Registered Number

08357958 (England and Wales)
Medishout Ltd
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets37,16013,209
7,16013,209
Current assets
Debtors210,58915,114
Cash at bank and on hand1,968,6012,644,769
2,179,1902,659,883
Creditors amounts falling due within one year4(1,162,371)(100,903)
Net current assets (liabilities)1,016,8192,558,980
Total assets less current liabilities1,023,9792,572,189
Net assets1,023,9792,572,189
Capital and reserves
Called up share capital22
Share premium5,467,0005,467,000
Profit and loss account(4,443,023)(2,894,813)
Shareholders' funds1,023,9792,572,189
The financial statements were approved and authorised for issue by the Board of Directors on 15 July 2025, and are signed on its behalf by:
KALRAIYA, Ashish Jain, Dr
Director
Registered Company No. 08357958
Medishout Ltd
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Office Equipment3
2.Average number of employees

20242023
Average number of employees during the year1612
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 January 2424,33624,336
At 31 December 2424,33624,336
Depreciation and impairment
At 01 January 2411,12711,127
Charge for year6,0496,049
At 31 December 2417,17617,176
Net book value
At 31 December 247,1607,160
At 31 December 2313,20913,209
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables75,43747,641
Payments received on account1,000,000-
Other creditors79,58453,262
Accrued liabilities and deferred income7,350-
Total1,162,371100,903
5.Creditors: amounts due after one year
6.Events after reporting date
In April 2025 additional Ordinary & Preference shares were issued to bring the total capital investment to £11.2m this included £1 million received before the Balance Sheet date of 31st December 2024 and is held on the balance sheet at the year-end date.